Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies

  • Cari M. Kitahara
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.
  • Marjorie L. McCullough
    Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
  • Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France.
  • Sabina Rinaldi
    International Agency for Research on Cancer, Lyon, France.
  • Alicja Wolk
    Division of Nutritional Epidemiology, Institute of Environmental Medicine; Karolinska Institutet, Stockholm, Sweden
  • Gila Neta
    Division of Cancer Control and Population Sciences; National Cancer Institute, Rockville, Maryland.
  • Hans Olov Adami
    Department of Medical Epidemiology and Biostatistics; Karolinska Institutet, Stockholm, Sweden.
  • Kristin Anderson
    Division of Epidemiology and Community Health, School of Public Health; University of Minnesota, Minneapolis, Minnesota.
  • Gabriella Andreotti
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.
  • Laura E. Beane Freeman
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.
  • Leslie Bernstein
    Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, California.
  • Julie E. Buring
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
  • Francoise Clavel-Chapelon
    Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Villejuif, France Paris South University, UMRS Inserm 1018 Team 9, Villejuif, France.
  • Lisa A. De Roo
    Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Yu-Tang Gao
    Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • J. Michael Gaziano
    Division of Preventive Medicine, Department of Medicine; Brigham and Women's Hospital, Boston, Massachusetts.
  • Graham G. Giles
    Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
  • Niclas Håkansson
    Division of Nutritional Epidemiology, Institute of Environmental Medicine; Karolinska Institutet, Stockholm, Sweden
  • Pamela L. Horn-Ross
    Cancer Prevention Institute of California, Fremont, California.
  • Vicki A. Kirsh
    Prevention and Cancer Control, Cancer Care Ontario, Toronto, Canada.
  • Martha S. Linet
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.
  • Robert J. MacInnis
    Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
  • Nicola Orsini
    Division of Nutritional Epidemiology, Institute of Environmental Medicine; Karolinska Institutet, Stockholm, Sweden
  • Yikyung Park
    Division of Public Health Sciences, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
  • Alpa V. Patel
    Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
  • Mark P. Purdue
    Ontario Institute for Cancer Research, Toronto, Canada.
  • Elio Riboli
    Imperial School of Public Health, Imperial College London, London, United Kingdom.
  • Kimberly Robien
    Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC.
  • Thomas Rohan
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
  • Dale P. Sandler
    Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
  • Catherine Schairer
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.
  • Arthur B. Schneider
    Section of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois.
  • Howard D. Sesso
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
  • Xiao-Ou Shu
    Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Pramil N. Singh
    Center for Health Research, School of Public Health, Loma Linda University, Loma Linda, California.
  • Piet A. van den Brandt
    Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
  • Elizabeth Ward
    Intramural Research, American Cancer Society, Atlanta, Georgia.
  • Elisabete Weiderpass
    Department of Medical Epidemiology and Biostatistics; Karolinska Institutet, Stockholm, Sweden.
  • Emily White
    Public Health Services Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Yong-Bing Xiang
    Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Anne Zeleniuch-Jacquotte
    Division of Epidemiology, Department of Population Health and NYU Cancer Institute, NYU School of Medicine, New York, New York.
  • Wei Zheng
    Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Patricia Hartge
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.
  • Amy Berrington de González
    Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville, Maryland.

収録刊行物

  • Thyroid

    Thyroid 26 (2), 306-318, 2016-02

    Mary Ann Liebert Inc

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ